28 October 2019 - White House, Congress seek action this year, but conflicts and possible impeachment present logistical hurdles.

Congressional law makers who pledged to lower drug prices are confronting the prospect that intra-party divides and possible impeachment proceedings may prevent them from getting anything major done this year.

The White House, eager for a win as other drug-price initiatives have sputtered, is pushing Congress to compromise, but a plan in the Democratic controlled House has become saddled with demands from progressives who say it doesn’t go far enough, and a bipartisan Senate bill is also on shaky ground.

Read Wall Street Journal article